Clinical Trial Update: N-Acetylcysteine vs Placebo as Adjunctive Treatment in Pediatric Leukemia [Phase 4]

View source ↗

Summary

Phase 4 trial assessing N-Acetylcysteine as adjunctive treatment versus placebo in pediatric acute lymphoblastic leukemia; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia in Children

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Teny Tjitra Sari | Conditions: Lymphoblastic Leukemia, Acute, Childhood | Phase 4 | Status: TERMINATED